Invention Publication
- Patent Title: METHODS FOR DIAGNOSING HEMATOLOGICAL CANCERS
-
Application No.: US18737392Application Date: 2024-06-07
-
Publication No.: US20240329046A1Publication Date: 2024-10-03
- Inventor: Martin Villalba Gonzalez , Ewelina Krzywinska
- Applicant: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) , CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER
- Applicant Address: FR Paris
- Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER
- Current Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER
- Current Assignee Address: FR Paris
- Priority: EP 306134.9 2014.07.11 EP 305011.7 2015.01.07
- Main IPC: G01N33/574
- IPC: G01N33/574
Abstract:
The present invention relates to methods for diagnosing hematological cancers. In particular, the present invention relates to a method for diagnosing a hematological cancer in a patient comprising i) detecting the presence of CD45RARO NK cells in a sample obtained from the patient and ii) and concluding that the patient suffers from a hematological cancer when the presence of CD45RARO NK cells is detected in the sample and the presence of at least one phenotypic marker indicates the nature of the haematological cancer.
Information query
IPC分类:
